Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ostiio is a private medical device company developing a fully implantable, magnetically driven distraction osteogenesis system for children with craniofacial abnormalities and other skeletal deformities. Its lead product, the Ostiio Distraction System, is designed to be implanted under the skin and expanded wirelessly with precision, aiming to reduce complications associated with semi-buried distractors and to improve treatment compliance. The company focuses on conditions such as craniosynostosis and micrognathia, where skeletal growth restriction can impair neurologic development, breathing, and feeding. Ostiio positions its technology as a smarter craniofacial distraction solution that gives surgeons more control over treatment progress while reducing caregiver burden. The company appears to be an early-stage, venture-backed healthcare startup originating from the University of Pennsylvania ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ostiio.